Calmare TherapeuticsCTTC
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Calmare Therapeutics Inc. (CTTC) in their 13F filings. The largest holder was Jackson Wealth Management, LLC ($0).
- Company
- Calmare Therapeutics Inc.
- CUSIP
- 13126R102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Jackson Wealth Management, LLC | 0.00% | No change | 126,906 | $0 |
"% of holder's portfolio" is CTTC's weight in each manager's 13F, not the share of Calmare Therapeutics Inc. the manager owns.